DNA FISH Probes

CGI FISH Probes are currently being used to confirm diagnosis in Leukemia, Lymphoma and Hematological disorders in major cancer centers in Europe.

The company is focused on developing an expanding portfolio of DNA FISH probe products in the areas of leukemia, lymphoma, multiple myeloma (MM), myelodysplastic syndrome (MDS), renal cancers, cervical and other HPV associated cancers.

CGI’s DNA-FISH probes are manufactured in Italy by Cancer Genetics Italia S.r.l. and are not commercially available in the US at this time. CGI provides innovative diagnostic reagents of the highest sensitivity and specificity to the clinical community in the European Union and the rest of the world. CGI S.r.l. is located in Milan, Italy. For further information, please go to http://www.cancergeneticsitalia.com.

CGI Innovation, Knowledge, Leadership

CGI is focused on delivering products and services that drive the highest levels of patient value. To achieve this, we have developed a corporate culture that inspires innovation, respects knowledge and fosters leadership.

CGI Personalized Medicine Services

CGI’s dedicated staff takes pride in our specialized laboratory services, superior turnaround time (TAT), enhanced reporting, EMR integration, and ongoing research and development for new tests.

CGI’s full-service cancer genetic practice and path to innovation with research makes for optimal patient care management.